These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8604514)

  • 1. Institutional variation in hemotherapy for solid organ transplantation.
    Danielson CF; Filo RS; O'Donnell JA; McCarthy LJ
    Transfusion; 1996 Mar; 36(3):263-7. PubMed ID: 8604514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of transfusion-acquired CMV infection in seronegative solid-organ transplant recipients receiving non-WBC-reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center.
    Preiksaitis JK; Sandhu J; Strautman M
    Transfusion; 2002 Apr; 42(4):396-402. PubMed ID: 12076284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specialized transfusion support for solid organ transplantation.
    Triulzi DJ
    Curr Opin Hematol; 2002 Nov; 9(6):527-32. PubMed ID: 12394177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current state of transfusion practices for ABO-incompatible pediatric heart transplant patients in the United States and Canada.
    Dean CL; Sullivan HC; Stowell SR; Fasano RM; West LJ; Robitaille N; Josephson CD
    Transfusion; 2018 Sep; 58(9):2243-2249. PubMed ID: 30145826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion support in liver transplantation.
    Triulzi DJ
    Curr Hematol Rep; 2004 Nov; 3(6):444-9. PubMed ID: 15496279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey on Transfusion-Transmitted Cytomegalovirus and Cytomegalovirus Disease Mitigation.
    Weisberg SP; Staley EM; Williams LA; Pham HP; Bachegowda LS; Cheng YH; Schwartz J; Shaz BH
    Arch Pathol Lab Med; 2017 Dec; 141(12):1705-1711. PubMed ID: 28849943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion Requirements and Blood Bank Support in Heart and Lung Transplantation.
    Yoo DW; Lee HJ; Oh SH; Kim IS; Kim HH; Je HG; Kim D; Cho WH; Kim JS; Lee SY; Yeo HJ
    Lab Med; 2021 Jan; 52(1):74-79. PubMed ID: 32700736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion in CMV seronegative T-depleted allogeneic stem cell transplant recipients with CMV-unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction: a U.K. dual centre experience.
    Hall S; Danby R; Osman H; Peniket A; Rocha V; Craddock C; Murphy M; Chaganti S
    Transfus Med; 2015 Dec; 25(6):418-23. PubMed ID: 26114211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for auditing pediatric blood transfusion practices.
    Blanchette VS; Hume HA; Levy GJ; Luban NL; Strauss RG
    Am J Dis Child; 1991 Jul; 145(7):787-96. PubMed ID: 1647658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of screening for antibodies to cytomegalovirus in organ transplantation].
    Milbradt H; Flik J; Stangel W; Heigel R
    Beitr Infusionsther; 1990; 26():33-6. PubMed ID: 1703866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients.
    Narvios AB; Przepiorka D; Tarrand J; Chan KW; Champlin R; Lichtiger B
    Bone Marrow Transplant; 1998 Sep; 22(6):575-7. PubMed ID: 9758346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-Dependent Association Between Pre-transplant Blood Transfusion and Outcomes of Pediatric Heart Transplantation.
    McKee C; Tumin D; Alevriadou BR; Nicol KK; Yates AR; Hayes D; Tobias JD
    Pediatr Cardiol; 2018 Apr; 39(4):743-748. PubMed ID: 29340730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: leucoreduction vs. cytomegalovirus-seronegative.
    Smith D; Lu Q; Yuan S; Goldfinger D; Fernando LP; Ziman A
    Vox Sang; 2010 Jan; 98(1):29-36. PubMed ID: 19695013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prevention of cytomegalovirus infection and disease by administration of biological products].
    Ihara T
    Nihon Rinsho; 1998 Jan; 56(1):145-50. PubMed ID: 9465680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters.
    van Prooijen HC; Visser JJ; van Oostendorp WR; de Gast GC; Verdonck LF
    Br J Haematol; 1994 May; 87(1):144-7. PubMed ID: 7947238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative blood transfusion in pediatric patients undergoing renal transplant-Effect of renal graft size.
    Odeh RI; Sidler M; Skelton T; Zu'bi F; Naoum NK; Azzawayed IA; Alyami FA; Lorenzo AJ; Farhat WA; Koyle MA
    Pediatr Transplant; 2018 May; 22(3):e13119. PubMed ID: 29488289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National survey of neonatal transfusion practices: II. Blood component therapy.
    Strauss RG; Levy GJ; Sotelo-Avila C; Albanese MA; Hume H; Schloz L; Blazina J; Werner A; Barrasso C; Blanchette V
    Pediatrics; 1993 Mar; 91(3):530-6. PubMed ID: 8382782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
    Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provision of cellular blood components to CMV-seronegative patients undergoing allogeneic stem cell transplantation in the UK: survey of UK transplant centres.
    Morton S; Peniket A; Malladi R; Murphy MF
    Transfus Med; 2017 Dec; 27(6):444-450. PubMed ID: 28913908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role and impact of the transfusion medicine consultation service in the management of patients in the hematopoietic transplant service: A retrospective analysis.
    Narvios A; Rodriguez-Jackson L; Reddy V; Lichtiger B
    Transfus Clin Biol; 2009 Sep; 16(4):383-7. PubMed ID: 19665413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.